"On June 2, 2021, the Israeli Ministry of Health announced that it believes there is a “probable link” between Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19 and dozens of cases of myocarditis (inflammation of the heart) in Israel—mostly in males between 16-30 years of age. According to an epidemiological study undertaken by a team of researchers lead by Dror Mevorach, MD of Hadassah Medical Center in Jerusalem, one out of 5,000 young men who receive the shot may experience this heart condition after getting the shot.1 2 3 4 5 6....

The study, conducted by public health experts from Israel’s Department of Epidemiology and National Center for Disease Control and representatives from Tel Aviv University, Haifa University and the Technion institute, observed that most of the cases of myocarditis occurred within one to five days after getting the second dose, suggesting that the timing of the symptoms experienced by patients does not appear to be rand